Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Langenbeck's Archives of Surgery
Erschienen in: Langenbeck's Archives of Surgery 1/2011

01.01.2011 | Review Article

Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences

verfasst von: Brigitte Vollmar, Michael D. Menger

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Intestinal ischemia and reperfusion (I/R) is a challenging and life-threatening clinical problem with diverse causes. The delay in diagnosis and treatment contributes to the continued high in-hospital mortality rate.

Results

Experimental research during the last decades could demonstrate that microcirculatory dysfunctions are determinants for the manifestation and propagation of intestinal I/R injury. Key features are nutritive perfusion failure, inflammatory cell response, mediator surge and breakdown of the epithelial barrier function with bacterial translocation, and development of a systemic inflammatory response. This review provides novel insight into the basic mechanisms of damaged intestinal microcirculation and covers therapeutic targets to attenuate intestinal I/R injury.

Conclusion

The opportunity now exists to apply this insight into the translation of experimental data to clinical trial-based research. Understanding the basic events triggered by intestinal I/R may offer new diagnostic and therapeutic options in order to achieve improved outcome of patients with intestinal I/R injury.
Literatur
1.
Yasuhara H (2005) Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today 35:185–195CrossRefPubMed
2.
Bradbury AW, Brittenden J, McBride K, Ruckley CV (1995) Mesenteric ischaemia: a multidisciplinary approach. Br J Surg 82:1446–1459CrossRefPubMed
3.
Stoney RJ, Cunningham CG (1993) Acute mesenteric ischemia. Surgery 114:489–490PubMed
4.
Acosta S (2010) Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg 23:4–8CrossRefPubMed
5.
Brandt LJ, Boley SJ (2000) AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology 118:954–968CrossRefPubMed
6.
Soong CV, Blair PH, Halliday MI, McCaigue MD, Hood JM, Rowlands BJ, D’SA B (1994) Bowel ischaemia and organ impairment in elective abdominal aortic aneurysm repair. Br J Surg 81:965–968CrossRefPubMed
7.
Gennaro M, Ascer E, Matano R, Jacobowitz IJ, Cunningham JN Jr, Uceda P (1993) Acute mesenteric ischemia after cardiopulmonary bypass. Am J Surg 166:231–236CrossRefPubMed
8.
Mangus R, Vianna R, Tector A (2009) Intestinal transplantation: an overview. Minerva Chir 64:45–57PubMed
9.
Granger DN, Richardson PD, Kvietys PR, Mortillaro NA (1980) Intestinal blood flow. Gastroenterology 78:837–863PubMed
10.
Parks DA, Granger DN (1986) Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 250:G749–G753PubMed
11.
Lanciault G, Jacobson ED (1976) The gastrointestinal circulation. Gastroenterology 71:851–873PubMed
12.
Shepherd AP (1982) Local control of intestinal oxygenation and blood flow. Annu Rev Physiol 44:13–27CrossRefPubMed
13.
Hansen MB, Dresner LS, Wait RB (1998) Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. Physiol Res 47:307–327PubMed
14.
Parks DA, Jacobson ED (1985) Physiology of the splanchnic circulation. Arch Intern Med 145:1278–1281CrossRefPubMed
15.
Lundgren O (1989) Autoregulation of intestinal blood flow: physiology and pathophysiology. J Hypertens Suppl 7:S79–S84PubMed
16.
Guan Y, Worrell RT, Pritts TA, Montrose MH (2009) Intestinal ischemia-reperfusion injury: reversible and irreversible damage imaged in vivo. Am J Physiol Gastrointest Liver Physiol 297:G187–G196CrossRefPubMed
17.
Knichwitz G, Brüssel T, Reinhold P, Schaumann F, Richter KD, Van Aken H (2000) Early onset of regional intestinal ischemia can be detected with carbon dioxide tension measurement inside the peritoneal cavity. Anesth Analg 91:1182–1187CrossRefPubMed
18.
Ghyczy M, Torday C, Kaszaki J, Szabó A, Czóbel M, Boros M (2008) Oral phosphatidylcholine pretreatment decreases ischemia-reperfusion-induced methane generation and the inflammatory response in the small intestine. Shock 30:596–602CrossRefPubMed
19.
Solligård E, Juel IS, Spigset O, Romundstad P, Grønbech JE, Aadahl P (2008) Gut luminal lactate measured by microdialysis mirrors permeability of the intestinal mucosa after ischemia. Shock 29:245–251PubMed
20.
Cruz RJ Jr, Garrido AG, Ribeiro CM, Harada T, Rocha-e-Silva M (2010) Regional blood flow distribution and oxygen metabolism during mesenteric ischemia and congestion. J Surg Res 161:54–61CrossRefPubMed
21.
Schwarz B, Hofstötter H, Salak N, Pajk W, Knotzer H, Mayr A, Labeck B, Kafka R, Ulmer H, Hasibeder W (2001) Effects of norepinephrine and phenylephrine on intestinal oxygen supply and mucosal tissue oxygen tension. Intensive Care Med 27:593–601CrossRefPubMed
22.
Lo CC, Chen JC, Chen HM, Shyr MH, Lau YT, Lin JN, Chen MF (1999) Aminoguanidine attenuates hemodynamic and microcirculatory derangement in rat intestinal ischemia and reperfusion. J Trauma 47:1108–1113CrossRefPubMed
23.
Solligård E, Wahba A, Skogvoll E, Stenseth R, Grønbech JE, Aadahl P (2007) Endoluminal microdialysis shows increased rectal lactate in routine coronary surgery. Anaesthesia 62:250–258CrossRefPubMed
24.
Solligård E, Juel IS, Bakkelund K, Jynge P, Tvedt KE, Johnsen H, Aadahl P, Grønbech JE (2005) Gut luminal microdialysis of glycerol as a marker of intestinal ischemic injury and recovery. Crit Care Med 33:2278–2285CrossRefPubMed
25.
Solligård E, Juel IS, Bakkelund K, Johnsen H, Saether OD, Grønbech JE, Aadahl P (2004) Gut barrier dysfunction as detected by intestinal luminal microdialysis. Intensive Care Med 30:1188–1194CrossRefPubMed
26.
Toens C, Krones CJ, Blum U, Fernandez V, Grommes J, Hoelzl F, Stumpf M, Klinge U, Schumpelick V (2006) Validation of IC-VIEW fluorescence videography in a rabbit model of mesenteric ischaemia and reperfusion. Int J Colorectal Dis 21:332–338CrossRefPubMed
27.
Massberg S, Leiderer R, Gonzalez AP, Menger MD, Messmer K (1998) Carolina rinse attenuates post-ischemic microvascular injury in rat small bowel isografts. Surgery 123:181–190PubMed
28.
Szabó A, Vollmar B, Boros M, Menger MD (2006) Gender differences in ischemia-reperfusion-induced microcirculatory and epithelial dysfunctions in the small intestine. Life Sci 78:3058–3065CrossRefPubMed
29.
Gonzalez AP, Sepulveda S, Massberg S, Baumeister R, Menger MD (1994) In vivo fluorescence microscopy for the assessment of microvascular reperfusion injury in small bowel transplants in rats. Transplantation 58:403–408CrossRefPubMed
30.
Mallick IH, Yang W, Winslet MC, Seifalian AM (2005) Protective effects of ischemic preconditioning on the intestinal mucosal microcirculation following ischemia-reperfusion of the intestine. Microcirculation 12:615–625CrossRefPubMed
31.
Bulkley GB, Kvietys PR, Parks DA, Perry MA, Granger DN (1985) Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine. Gastroenterology 89:852–857PubMed
32.
Boley SJ, Brandt LJ, Veith FJ (1978) Ischemic disorders of the intestines. Curr Probl Surg 15:1–85CrossRefPubMed
33.
Wilcox MG, Howard TJ, Plaskon LA, Unthank JL, Madura JA (1995) Current theories of pathogenesis and treatment of nonocclusive mesenteric ischemia. Dig Dis Sci 40:709–716CrossRefPubMed
34.
Mallick IH, Yang W, Winslet MC, Seifalian AM (2004) Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 49:1359–1377CrossRefPubMed
35.
Kurose I, Granger DN (1994) Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann NY Acad Sci 723:158–179CrossRefPubMed
36.
Schoenberg MH, Beger HG (1993) Reperfusion injury after intestinal ischemia. Crit Care Med 21:1376–1386CrossRefPubMed
37.
Menger MD, Vollmar B (2000) Role of microcirculation in transplantation. Microcirculation 7:291–306PubMed
38.
McCord JM (1985) Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 312:159–163CrossRefPubMed
39.
Massberg S, Gonzalez AP, Leiderer R, Menger MD, Messmer K (1998) In vivo assessment of the influence of cold preservation time on microvascular reperfusion injury after experimental small bowel transplantation. Br J Surg 85:127–133CrossRefPubMed
40.
Beuk RJ, Heineman E, Tangelder GJ, Quaedackers JS, Marks WH, Lieberman JM, Oude Egbrink MG (2000) Total warm ischemia and reperfusion impairs flow in all rat gut layers but increases leukocyte-vessel wall interactions in the submucosa only. Ann Surg 231:96–104CrossRefPubMed
41.
Beuk RJ, Heineman E, Tangelder GJ, Kurvers HA, Bonke HJ, Oude Egbrink MG (1997) Effects of different durations of total warm ischemia of the gut on rat mesenteric microcirculation. J Surg Res 73:14–23CrossRefPubMed
42.
Beuk RJ, Tangelder GJ, Maassen RL, Quaedackers JS, Heineman E, Oude Egbrink MG (2008) Leucocyte and platelet adhesion in different layers of the small bowel during experimental total warm ischaemia and reperfusion. Br J Surg 95:1294–1304CrossRefPubMed
43.
Megison SM, Horton JW, Chao H, Walker PB (1990) A new model for intestinal ischemia in the rat. J Surg Res 49:168–173CrossRefPubMed
44.
Gayle J, Jones SL, Argenzio RA, Blikslager AT (2002) Neutrophils increase paracellular permeability of restituted ischemic-injured porcine ileum. Surgery 132:461–470CrossRefPubMed
45.
Kalia N, Pockley AG, Wood RF, Brown NJ (2002) Effects of hypothermia and rewarming on the mucosal villus microcirculation and survival after rat intestinal ischemia-reperfusion injury. Ann Surg 236:67–74CrossRefPubMed
46.
Szabó A, Vollmar B, Boros M, Menger MD (2008) In vivo fluorescence microscopic imaging for dynamic quantitative assessment of intestinal mucosa permeability in mice. J Surg Res 145:179–185CrossRefPubMed
47.
Menger MD, Rücker M, Vollmar B (1997) Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary “no-reflow”. Shock 8:2–7CrossRefPubMed
48.
Schoots IG, Levi M, Roossink EH, Bijlsma PB, van Gulik TM (2003) Local intravascular coagulation and fibrin deposition on intestinal ischemia-reperfusion in rats. Surgery 133:411–419CrossRefPubMed
49.
House SD, Lipowsky HH (1988) In vivo determination of the force of leukocyte-endothelium adhesion in the mesenteric microvasculature of the cat. Circ Res 63:658–668PubMed
50.
Jonas J, Heimann A, Strecker U, Kempski O (2000) Hypertonic/hyperoncotic resuscitation after intestinal superior mesenteric artery occlusion: early effects on circulation and intestinal reperfusion. Shock 14:24–29CrossRefPubMed
51.
Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, Sheth SU, Caputo FJ, Lu Q, Ramanathan M, Attan S, Badami CD, Doucet D, Barlos D, Bosch-Marce M, Semenza GL, Xu DZ (2010) HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 299:G833–G843CrossRefPubMed
52.
Sukhotnik I, Brod V, Lurie M, Rahat MA, Shnizer S, Lahat N, Mogilner JG, Bitterman H (2009) The effect of 100% oxygen on intestinal preservation and recovery following ischemia-reperfusion injury in rats. Crit Care Med 37:1054–1061CrossRefPubMed
53.
Waisman D, Brod V, Wolff R, Sabo E, Chernin M, Weintraub Z, Rotschild A, Bitterman H (2003) Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion. Am J Physiol Heart Circ Physiol 285:H643–H652PubMed
54.
Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068–2101PubMed
55.
Eppihimer MJ, Russell J, Anderson DC, Epstein CJ, Laroux S, Granger DN (1997) Modulation of P-selectin expression in the post-ischemic intestinal microvasculature. Am J Physiol 273:G1326–G1332PubMed
56.
Riaz AA, Wan MX, Schaefer T, Schramm R, Ekberg H, Menger MD, Jeppsson B, Thorlacius H (2002) Fundamental and distinct roles of P-selectin and LFA-1 in ischemia/reperfusion-induced leukocyte-endothelium interactions in the mouse colon. Ann Surg 236:777–784CrossRefPubMed
57.
Braun F, Hosseini M, Wieland E, Sattler B, Laabs S, Lorf T, Müller AR, Fändrich F, Kremer B, Ringe B (2004) Expression of E-selectin and its transcripts during intestinal ischemia-reperfusion injury in pigs. Transplant Proc 36:265–266CrossRefPubMed
58.
Santen S, Schramm R, Menger MD, Wang Y, Jeppsson B, Thorlacius H (2007) P-selectin glycoprotein ligand-1 regulates chemokine-dependent leukocyte recruitment in colonic ischemia-reperfusion. Inflamm Res 56:452–458CrossRefPubMed
59.
Ajuebor MN, Swain MG, Perretti M (2002) Chemokines as novel therapeutic targets in inflammatory diseases. Biochem Pharmacol 63:1191–1196CrossRefPubMed
60.
Santen S, Wang Y, Menger MD, Jeppsson B, Thorlacius H (2008) Mast-cell-dependent secretion of CXC chemokines regulates ischemia-reperfusion-induced leukocyte recruitment in the colon. Int J Colorectal Dis 23:527–534CrossRefPubMed
61.
Riaz AA, Schramm R, Sato T, Menger MD, Jeppsson B, Thorlacius H (2003) Oxygen radical-dependent expression of CXC chemokines regulate ischemia/reperfusion-induced leukocyte adhesion in the mouse colon. Free Radic Biol Med 35:782–789CrossRefPubMed
62.
Santen S, Wang Y, Laschke MW, Menger MD, Jeppsson B, Thorlacius H (2010) Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion. Int J Colorectal Dis 25:1063–1070CrossRefPubMed
63.
Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190:255–266CrossRefPubMed
64.
Shigematsu T, Wolf RE, Granger DN (2002) T-lymphocytes modulate the microvascular and inflammatory responses to intestinal ischemia-reperfusion. Microcirculation 9:99–109PubMed
65.
Watanabe C, Miura S, Hokari R, Teramoto K, Ogino T, Komoto S, Hara Y, Koseki S, Tsuzuki Y, Nagata H, Granger DN, Ishii H (2002) Spatial heterogeneity of TNF-alpha-induced T cell migration to colonic mucosa is mediated by MAdCAM-1 and VCAM-1. Am J Physiol Gastrointest Liver Physiol 283:G1379–G1387PubMed
66.
Fujimori H, Miura S, Koseki S, Hokari R, Komoto S, Hara Y, Hachimura S, Kaminogawa S, Ishii H (2002) Intravital observation of adhesion of lamina propria lymphocytes to microvessels of small intestine in mice. Gastroenterology 122:734–744CrossRefPubMed
67.
Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K (1998) Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92:507–515PubMed
68.
Cooper D, Chitman KD, Williams MC, Granger DN (2003) Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 284:G1027–G1033PubMed
69.
Massberg S, Enders G, Matos FC, Tomic LI, Leiderer R, Eisenmenger S, Messmer K, Krombach F (1999) Fibrinogen deposition at the post-ischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 94:3829–3838PubMed
70.
Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA (1996) Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97:1525–1534CrossRefPubMed
71.
Yeo EL, Sheppard JA, Feuerstein IA (1994) Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood 83:2498–2507PubMed
72.
Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schömig A (1997) Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95:2387–2394PubMed
73.
Salter JW, Krieglstein CF, Issekutz AC, Granger DN (2001) Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol 281:G1432–G1439PubMed
74.
Cooper D, Russell J, Chitman KD, Williams MC, Wolf RE, Granger DN (2004) Leukocyte dependence of platelet adhesion in post-capillary venules. Am J Physiol Heart Circ Physiol 286:H1895–H1900CrossRefPubMed
75.
Petnehazy T, Cooper D, Stokes KY, Russell J, Wood KC, Granger DN (2006) Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion. Am J Physiol Gastrointest Liver Physiol 290:G1203–G1210CrossRefPubMed
76.
Riaz AA, Wang Y, Schramm R, Sato T, Menger MD, Jeppsson B, Thorlacius H (2004) Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J 18:881–883PubMed
77.
Watson MJ, Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW, Farmer DG (2008) Intestinal ischemia/reperfusion injury triggers activation of innate toll-like receptor four and adaptive chemokine programs. Transplant Proc 40:3339–3341CrossRefPubMed
78.
Moses T, Wagner L, Fleming SD (2009) TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol 86:971–980CrossRefPubMed
79.
Victoni T, Coelho FR, Soares AL, de Freitas A, Secher T, Guabiraba R, Erard F, de Oliveira-Filho RM, Vargaftig BB, Lauvaux G, Kamal MA, Ryffel B, Moser R, Tavares-de-Lima W (2010) Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med Microbiol Immunol 199:35–42CrossRefPubMed
80.
Aprahamian CJ, Lorenz RG, Harmon CM, Dimmit RA (2008) Toll-like receptor two is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr Crit Care Med 9:105–109CrossRefPubMed
81.
Vasileiou I, Kostopanagiotou G, Katsargyris A, Klonaris C, Perrea D, Theocharis S (2010) Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury? Expert Opin Ther Targets 14:839–853CrossRefPubMed
82.
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136PubMed
83.
Wolfárd A, Kaszaki J, Varga S, Lázár G, Boros M (2007) Early microcirculatory changes after ischemic preconditioning and small bowel autotransplantation. Eur Surg Res 39:284–290CrossRefPubMed
84.
Moore-Olufemi SD, Olufemi SE, Lott S, Sato N, Kozar RA, Moore FA, Radhakrishnan RS, Shah S, Jimenez F, Kone BC, Cox CS Jr (2010) Intestinal ischemic preconditioning after ischemia/reperfusion injury in rat intestine: profiling global gene expression patterns. Dig Dis Sci 55:1866–1877CrossRefPubMed
85.
Mallick IH, Winslet MC, Seifalian AM (2010) Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg 199:223–231CrossRefPubMed
86.
McCallion K, Wattanasirichaigoon S, Gardiner KR, Fink MP (2000) Ischemic preconditioning ameliorates ischemia- and reperfusion-induced intestinal epithelial hyperpermeability in rats. Shock 14:429–434CrossRefPubMed
87.
Aksöyek S, Cinel I, Avlan D, Cinel L, Oztürk C, Gürbüz P, Nayci A, Oral U (2002) Intestinal ischemic preconditioning protects the intestine and reduces bacterial translocation. Shock 18:476–480CrossRefPubMed
88.
Sola A, De Oca J, González R, Prats N, Roselló-Catafau J, Gelpí E, Jaurrieta E, Hotter G (2001) Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg 234:98–106CrossRefPubMed
89.
Yusof M, Kamada K, Kalogeris T, Gaskin FS, Korthuis RJ (2009) Hydrogen sulfide triggers late-phase preconditioning in post-ischemic small intestine by an NO- and p38 MAPK-dependent mechanism. Am J Physiol Heart Circ Physiol 296:H868–H876CrossRefPubMed
90.
Kostopanagiotou G, Avgerinos ED, Markidou E, Voiniadis P, Chondros C, Theodoraki K, Smyrniotis V, Arkadopoulos N (2009) Protective effect of NAC preconditioning against ischemia-reperfusion injury in piglet small bowel transplantation: effects on plasma TNF, IL-8, hyaluronic acid, and NO. J Surg Res, doi:10.​1016/​j.​jss.​2009.​09.​002
91.
Sayan H, Ozacmak VH, Sen F, Cabuk M, Atik DY, Igdem AA, Ozacmak ID (2009) Pharmacological preconditioning with erythropoietin reduces ischemia-reperfusion injury in the small intestine of rats. Life Sci 84:364–371CrossRefPubMed
92.
Gaskin FS, Kamada K, Yusof M, Durante W, Gross G, Korthuis RJ (2009) AICAR preconditioning prevents post-ischemic leukocyte rolling and adhesion: role of K(ATP) channels and heme oxygenase. Microcirculation 16:167–176CrossRefPubMed
93.
Yamaguchi T, Dayton C, Shigematsu T, Carter P, Yoshikawa T, Gute DC, Korthuis RJ (2002) Preconditioning with ethanol prevents post-ischemic leukocyte–endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 283:H1019–H1030PubMed
94.
Li J, Zhang M, Yang C, Dun Y, Zhang Y, Hao Y (2009) Nitroglycerin protects small intestine from ischemia-reperfusion injury via NO-cGMP pathway and upregulation of alpha-CGRP. J Gastrointest Surg 13:478–485CrossRefPubMed
95.
Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha FQ, Teixeira MM, Souza DG (2007) Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur J Pharmacol 556:215–222CrossRefPubMed
96.
Davis JM, Gute DC, Jones S, Krsmanovic A, Korthuis RJ (1999) Ischemic preconditioning prevents post-ischemic P-selectin expression in the rat small intestine. Am J Physiol 277:H2476–H2481PubMed
97.
Ferencz A, Takács I, Horváth S, Ferencz S, Jávor S, Fekecs T, Shanava K, Balatonyi B, Wéber G (2010) Examination of protective effect of ischemic post-conditioning after small bowel autotransplantation. Transplant Proc 42:2287–2289CrossRefPubMed
98.
Liu KX, Li YS, Huang WQ, Chen SQ, Wang ZX, Liu JX, Xia Z (2009) Immediate post-conditioning during reperfusion attenuates intestinal injury. Intensive Care Med 35:933–942CrossRefPubMed
99.
Li YS, Wang ZX, Li C, Xu M, Li Y, Huang WQ, Xia Z, Liu KX (2010) Proteomics of ischemia/reperfusion injury in rat intestine with and without ischemic post-conditioning. J Surg Res 164:e173–e180CrossRefPubMed
100.
Oltean M, Pullerits R, Zhu C, Blomgren K, Hallberg EC, Olausson M (2007) Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats. Surgery 141:667–677CrossRefPubMed
101.
Akiyoshi J, Ieiri S, Nakatsuji T, Taguchi T (2009) Direct vasodilative effect of FK506 on porcine mesenteric artery in small bowel transplantation. J Pediatr Surg 44:2322–2326CrossRefPubMed
102.
Attuwaybi BO, Hassoun HT, Zou L, Kozar RA, Kone BC, Weisbrodt NW, Moore FA (2003) Hypothermia protects against gut ischemia/reperfusion-induced impaired intestinal transit by inducing heme oxygenase-1. J Surg Res 115:48–55CrossRefPubMed
103.
Sakamoto N, Kokura S, Okuda T, Hattori T, Katada K, Isozaki Y, Nakabe N, Handa O, Takagi T, Ishikawa T, Naito Y, Yoshida N, Yoshikawa T (2005) Heme oxygenase-1 (Hsp32) is involved in the protection of small intestine by whole body mild hyperthermia from ischemia/reperfusion injury in rat. Int J Hyperthermia 21:603–614CrossRefPubMed
104.
Nüssler NC, Müller AR, Weidenbach H, Vergopoulos A, Platz KP, Volk HD, Neuhaus P, Nussler AK (2003) IL-10 increases tissue injury after selective intestinal ischemia/reperfusion. Ann Surg 238:49–58CrossRefPubMed
105.
Bauer I, Pannen BH (2009) Bench-to-bedside review: carbon monoxide–from mitochondrial poisoning to therapeutic use. Crit Care 13:220CrossRefPubMed
106.
Nakao A, Kaczorowski DJ, Sugimoto R, Billiar TR, McCurry KR (2008) Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J Clin Biochem Nutr 42:78–88CrossRefPubMed
107.
Katada K, Bihari A, Mizuguchi S, Yoshida N, Yoshikawa T, Fraser DD, Potter RF, Cepinskas G (2010) Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation 33:92–100CrossRefPubMed
108.
Nakao A, Kimizuka K, Stolz DB, Seda Neto J, Kaizu T, Choi AM, Uchiyama T, Zuckerbraun BS, Bauer AJ, Nalesnik MA, Otterbein LE, Geller DA, Murase N (2003) Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts. Surgery 134:285–292CrossRefPubMed
109.
Attuwaybi B, Kozar RA, Gates KS, Moore-Olufemi S, Sato N, Weisbrodt NW, Moore FA (2004) Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J Trauma 56:749–758CrossRefPubMed
110.
Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR (2008) Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury–a review. J Surg Res 150:304–330CrossRefPubMed
111.
Iba T, Kidokoro A, Fukunaga M, Takuhiro K, Ouchi M, Ito Y (2006) Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock 26:522–526CrossRefPubMed
112.
Souza DG, Cassali GD, Poole S, Teixeira MM (2001) Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 134:985–994CrossRefPubMed
113.
Ilhan H, Alatas O, Tokar B, Çolak O, Paşaoĝlu O, Koku N (2003) Effects of the anti-ICAM-1 monoclonal antibody, allopurinol, and methylene blue on intestinal reperfusion injury. J Pediatr Surg 38:1591–1595CrossRefPubMed
114.
Sun Z, Wang X, Lasson A, Böjesson A, Annborn M, Andersson R (2001) Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol 36:55–65CrossRefPubMed
115.
Farmer DG, Anselmo D, Da Shen X, Ke B, Carmody IC, Gao F, Lassman C, McDiarmid SV, Shaw G, Busuttil RW, Kupiec-Weglinski JW (2005) Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation 80:828–835CrossRefPubMed
116.
Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14:1315–1323CrossRefPubMed
117.
Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK (2009) Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 182:3965–3968CrossRefPubMed
118.
Di Paola R, Melani A, Esposito E, Mazzon E, Paterniti I, Bramanti P, Pedata F, Cuzzocrea S (2010) Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury. Shock 33:541–551PubMed
119.
Menger MD, Vollmar B (2007) Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds? Transplant Proc 39:485–488CrossRefPubMed
120.
Mori S, Sawada T, Okada T, Kubota K (2008) Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat. Surgery 143:556–565CrossRefPubMed
121.
Guneli E, Cavdar Z, Islekel H, Sarioglu S, Erbayraktar S, Kiray M, Sokmen S, Yilmaz O, Gokmen N (2007) Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol Med 13:509–517CrossRefPubMed
122.
Naito Y, Katada K, Takagi T, Tsuboi H, Kuroda M, Handa O, Kokura S, Yoshida N, Ichikawa H, Yoshikawa T (2006) Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein. World J Gastroenterol 12:2024–2030PubMed
123.
Slijper N, Sukhotnik I, Chemodanov E, Bashenko Y, Shaoul R, Coran AG, Mogilner J (2010) Effect of simvastatin on intestinal recovery following gut ischemia-reperfusion injury in a rat. Pediatr Surg Int 26:105–110CrossRefPubMed
124.
Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, Bunzendaul H, Bradford B, Lemasters JJ (2003) L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care 6:229–240CrossRefPubMed
125.
Wan MX, Schramm R, Klintman D, Welzenbach K, Weitz-Schmidt G, Thorlacius H (2003) A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon. Br J Pharmacol 140:395–401CrossRefPubMed
126.
Qin X, Sheth SU, Sharpe SM, Dong W, Lu Q, Xu D, Deitch EA (2010) The mucus layer is critical in protecting against ischemia/reperfusion-mediated gut injury and in the restitution of gut barrier function. Shock, doi:10.​1097/​SHK.​0b013e3181f6aaf1​
127.
Bouritius H, van Hoorn DC, Oosting A, van Middelaar-Voskuilen MC, van Limpt CJ, Lamb KJ, van Leeuwen PA, Vriesema AJ, van Norren K (2008) Carbohydrate supplementation before operation retains intestinal barrier function and lowers bacterial translocation in a rat model of major abdominal surgery. JPEN J Parenter Enteral Nutr 32:247–253CrossRefPubMed
128.
Fujise T, Iwakiri R, Wu B, Amemori S, Kakimoto T, Yokoyama F, Sakata Y, Tsunada S, Fujimoto K (2006) Apoptotic pathway in the rat small intestinal mucosa is different between fasting and ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 291:G110–G116CrossRefPubMed
129.
Tatum PM Jr, Harmon CM, Lorenz RG, Dimmitt RA (2010) Toll-like receptor four is protective against neonatal murine ischemia-reperfusion intestinal injury. J Pediatr Surg 45:1246–1255CrossRefPubMed
130.
Chen LW, Chang WJ, Chen PH, Liu WC, Hsu CM (2008) TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling. Shock 30:563–570CrossRefPubMed
131.
Kozar RA, Verner-Cole E, Schultz SG, Sato N, Bick RJ, Desoignie R, Poindexter BJ, Moore FA (2004) The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J Trauma 57:1150–1156CrossRefPubMed
132.
Kozar RA, Schultz SG, Bick RJ, Poindexter BJ, DeSoignie R, Moore FA (2004) Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats. Shock 21:433–437CrossRefPubMed
133.
Sato N, Moore FA, Kone BC, Zou L, Smith MA, Childs MA, Moore-Olufemi S, Schultz SG, Kozar RA (2006) Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent post-ischemic small bowel. Am J Physiol Gastrointest Liver Physiol 290:G616–G623CrossRefPubMed
134.
McQuiggan M, Kozar R, Sailors RM, Ahn C, McKinley B, Moore F (2008) Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr 32:28–35CrossRefPubMed
135.
Ban K, Kozar RA (2008) Enteral glutamine: a novel mediator of PPARgamma in the post-ischemic gut. J Leukoc Biol 84:595–599CrossRefPubMed
Metadaten
Titel
Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences
verfasst von
Brigitte Vollmar
Michael D. Menger
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2011
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-010-0727-x

Weitere Artikel der Ausgabe 1/2011

Langenbeck's Archives of Surgery 1/2011 Zur Ausgabe

Original Article

Reduction of adhesion formation by an angiotensin type 1 receptor antagonist

Original Article

Mesenchymal stem cells improve the healing of ischemic colonic anastomoses (experimental study)

Original Paper

Mechanical bowel preparation and antimicrobial prophylaxis in elective colorectal surgery in Switzerland—a survey

Overview

The formal requirements of algorithms and their implications in clinical medicine and quality management

Editorial

Langenbeck’s archives of surgery 2011: new concepts and design

Original Article

Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.